Back to Search
STEPHEN STANZIALE, M.D.
M.D.
Specialist
NPI: 1326082645IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Angiographic lesion characteristics can predict adverse outcomes after carotid artery stenting.
PMID 18178457·J Vasc Surg·2008
8-other
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
PMID 17475966·J Nucl Med·2007
3-trial
Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer.
PMID 16685445·Int J Oncol·2006
8-other
Carotid artery stenting in octogenarians is associated with increased adverse outcomes.
PMID 16476605·J Vasc Surg·2006
4-observational
Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery.
PMID 16467372·FASEB J·2006
7-preclinical
Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging.
PMID 16446989·Surg Endosc·2006
7-preclinical
Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
PMID 16138120·Cancer Gene Ther·2006
7-preclinical
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.
PMID 16037824·Cancer Gene Ther·2006
7-preclinical
Determining in-stent stenosis of carotid arteries by duplex ultrasound criteria.
PMID 15943510·J Endovasc Ther·2005
4-observational
Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer.
PMID 15212719·Hum Gene Ther·2004
4-observational
Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity.
PMID 15131064·Clin Cancer Res·2004
8-other
The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
PMID 12947341·Surgery·2003
8-other
Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
PMID 12637943·Cancer Gene Ther·2003
7-preclinical
Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase.
PMID 12219034·Surgery·2002
7-preclinical
Palatal adhesion: the treatment of unilateral palatal paralysis after high vagus nerve injury.
PMID 12203796·Head Neck·2002
8-other
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
PMID 11435585·J Virol·2001
7-preclinical
Unstable pelvic fracture and massive retroperitoneal hematoma from transection of the superior gluteal artery.
PMID 10744487·J Trauma·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2002 MEDICAL PKWY, STE 500
ANNAPOLIS, MD 21401 - Phone
- (410) 573-6480
Quick Facts
- NPI
- 1326082645
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile